Cover Image

Corrigendum to "Investigating the mechanisms of Xiaoyaosan on premenstrual dysphoric disorder using metabolomics technology" [Pharmacological Research - Modern Chinese Medicine 10C (2024) /100398] 2

Saved in:

Bibliographic Details
Main Authors:	Mengbai Xu (Author), Yueyun Liu (Author), Chenyue Liu (Author), Zhe Xue (Author), Jianbei Chen (Author), Yanfen Liu (Author), Jiaxu Chen (Author)
Format:	Book
Published:	Elsevier, 2024-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Investigating the mechanisms of Xiaoyaosan on premenstrual dysphoric disorder using metabolomics technology
by: Mengbai Xu, et al.
Published: (2024)

Metabolomics-based alleviation of depression by Xiaoyaosan through regulation of XDH and GRIA2
by: Chaofang Lei, et al.
Published: (2023)

Research progress on classical traditional chinese medicine formula xiaoyaosan in the treatment of depression
by: Jianbei Chen, et al.
Published: (2022)

Xiaoyaosan Ameliorates Chronic Restraint Stress-Induced Depression-Like Phenotype by Suppressing A2AR Signaling in the Rat Striatum
by: Xiaoxu Zhu, et al.
Published: (2022)

Effect of Xiaoyaosan on Colon Morphology and Intestinal Permeability in Rats With Chronic Unpredictable Mild Stress
by: Fengmin Ding, et al.
Published: (2020)

Corrigendum: Xiaoyaosan alleviates hippocampal glutamate-induced toxicity in the CUMS rats via NR2B and PI3K/Akt signaling pathway
by: Xueming Zhou, et al.
Published: (2022)

Premenstrual Syndrome and Premenstrual Dysphoric Disorder From the theory to the clinical approach
by: Danuta Maciejewska, et al.
Published: (2023)

Integrating Metabolomics and Network Analysis for Exploring the Mechanism Underlying the Antidepressant Activity of Paeoniflorin in Rats With CUMS-Induced Depression
by: Chaofang Lei, et al.
Published: (2022)

Diagnostic validity of premenstrual dysphoric disorder: revisited
by: Shalini S. Naik, et al.
Published: (2023)

Biological rhythms in premenstrual syndrome and premenstrual dysphoric disorder: a systematic review
by: Adile Nexha, et al.
Published: (2024)

Management of Premenstrual Dysphoric Disorder: A Scoping Review
by: Carlini SV, et al.
Published: (2022)

Network Pharmacology and Data Mining Approach Reveal the Medication Rule of Traditional Chinese Medicine in the Treatment of Premenstrual Syndrome/Premenstrual Dysphoric Disorder
by: Songlin Qu, et al.
Published: (2022)

Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in India: A systematic review and meta-analysis
by: Abhijit Dutta, et al.
Published: (2021)

Prevalence, pattern and predictors of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) among college girls
by: Anitha Durairaj, et al.
Published: (2019)

Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives
by: Rapkin AJ, et al.
Published: (2019)

Premenstrual dysphoric disorder is associated with the longer length from clitoris to urethra
by: Zheng Li, et al.
Published: (2021)

Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder
by: Anna Wikman, et al.
Published: (2022)

The complexity of premenstrual dysphoric disorder - risk factors in the population of Polish women
by: Nowosielski Krzysztof, et al.
Published: (2010)

Premenstrual Dysphoric Disorder Causes Discomfort And Interfere Adolescent's Social Relationship
by: Dewi Marfuah
Published: (2019)

Trends in Research Related to Premenstrual Syndrome and Premenstrual Dysphoric Disorder From 1945 to 2018: A Bibliometric Analysis
by: Mingzhou Gao, et al.
Published: (2021)

Comparison Quality of Life in the Three Groups: Women with Premenstrual Syndrome, Premenstrual Dysphoric Disorder and General Population in Yazd
by: Zohreh Karimain kakolaki, et al.
Published: (2019)

Lack of association of DRD3 and CNR1 polymorphisms with premenstrual dysphoric disorders
by: Mesut Yıldız, et al.
Published: (2015)

Exploring premenstrual dysphoric disorder (PMDD) in the work context: a qualitative study
by: Claire Hardy, et al.
Published: (2017)

Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review
by: Lete I, et al.
Published: (2016)

Women's experiences of receiving a diagnosis of premenstrual dysphoric disorder: a qualitative investigation
by: Elizabeth Osborn, et al.
Published: (2020)

The prevalence of moderate-severe premenstrual syndrome and premenstrual dysphoric disorder and the related factors in high school students: A cross‐sectional study
by: Farzaneh Babapour, et al.
Published: (2023)

Exploring diagnosis and treatment of premenstrual dysphoric disorder in the U.S. healthcare system: a qualitative investigation
by: Kiera Chan, et al.
Published: (2023)

Assessment of N-acetylcysteine as an Alternative for the Treatment of the Premenstrual Dysphoric Disorder: A Randomized Clinical Trial
by: Fatemeh Rajabi, et al.
Published: (2020)

Prevalence, phenomenology and personality characteristics of premenstrual dysphoric disorder among female students at Zagazig University, Egypt
by: Seham M. Eldeeb, et al.
Published: (2021)

Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder
by: Lesley L Breech, et al.
Published: (2009)

Corrigendum: Xiaoyaosan exerts antidepressant effect by downregulating RAGE expression in cingulate gyrus of depressive-like mice
by: Weixin Yan, et al.
Published: (2022)

Identification of emotion schemes in women with premenstrual dysphoric disorder (PMDD) using an emotion-focused therapy (EFT) approach: A qualitative study
by: Saeideh Izadi Dehnavi, et al.
Published: (2024)

Xiaoyaosan Improves Antibiotic-Induced Depressive-Like and Anxiety-Like Behavior in Mice Through Modulating the Gut Microbiota and Regulating the NLRP3 Inflammasome in the Colon
by: Wenzhi Hao, et al.
Published: (2021)

Xiaoyaosan Alleviates Hippocampal Glutamate-Induced Toxicity in the CUMS Rats via NR2B and PI3K/Akt Signaling Pathway
by: Xue-Ming Zhou, et al.
Published: (2021)

Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice
by: Yan Liu, et al.
Published: (2019)

Corrigendum: Modified Xiaoyaosan (MXYS) Exerts Anti-depressive Effects by Rectifying the Brain Blood Oxygen Level-Dependent FMRI Signals and Improving Hippocampal Neurogenesis in Mice
by: Lei Gao, et al.
Published: (2018)

Determinants of premenstrual dysphoric disorder and associated factors among regular undergraduate students at Hawassa University Southern, Ethiopia, 2023: institution-based cross-sectional study
by: Aklile Tsega Chekol, et al.
Published: (2024)

Antidepressant Mechanism of Traditional Chinese Medicine Formula Xiaoyaosan in CUMS-Induced Depressed Mouse Model via RIPK1-RIPK3-MLKL Mediated Necroptosis Based on Network Pharmacology Analysis
by: Zhi-Yi Yan, et al.
Published: (2021)

Dysphoric Milk Ejection Reflex: The Psychoneurobiology of the Breastfeeding Experience
by: Reem Deif, et al.
Published: (2021)

Dysphoric milk ejection reflex: A case report
by: Wiessinger Diane, et al.
Published: (2011)